Industry News/Funding

Grant Awarded To Develop Chromosome-Specific Telomere Gene Probes

Published in Gene Therapy Weekly, August 14th, 1995

Oncor, Inc., Gaithersburg, Maryland, announced that it has been awarded a $750,000 Phase II Small Business Innovation Research (SBIR) grant from the U.S. National Institutes of Health (NIH) for the molecular analysis of human telomeres.

Telomeres cap the end of the chromosomes and are critical for maintaining chromosome structure. Instability in the telomeric region has been associated with aging, cancer and mental retardation.

The changes in structure in this region have been very difficult to study due to their complexity and the normal variation that exists in the population. Oncor plans the development of a panel of chromosome-specific telomere...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-08-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry